SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Female Health FHCO
An SI Board Since November 2010
Posts SubjectMarks Bans Symbol
191 6 0 VERU
Emcee:  Savant Type:  Unmoderated
Introduction Market Data Compact
Makers of the female condom. Was FHCO, now VERU also with cancer drugs in development
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
191Second Quarter Financial Summary: Fiscal 2023 vs Fiscal 2022 -- Net revenuSavant-May 15
190 Agreement reached with FDA on confirmatory Phase 3 clinical trial designSavant-May 11
189Veru Enters Into Supply Agreement with Afaxys to Expand Access to FC2 FemalSavant-April 19
188Veru Announces Preclinical Results from Expanded Sabizabulin Program into InflueSavant-April 11
187Veru Announces Preclinical Study Results that Demonstrate Sabizabulin Inhibits PSavant-April 11
186VERU filed a $200 mln shelf offeringSavant-March 20
185Veru Inc. said Tuesday it may be forced to delay, reduce or eliminate cliniSavant-March 14
184Share of Veru Inc. (VERU) plunged 31.0% toward a 2 1/2-year low in premarkeSavant-March 3
183Investigation Alert GRNC, VERU, GPS, UIS: Johnson Fistel, LLP Encourages LoSavant-February 24
182Veru Reports Fiscal 2023 First Quarter Financial Results (globenewswire.com)Savant-February 9
181Veru Inc. (VERU) estimates and forecastsVeru Inc. share prices are performing paSavant-February 6
180VERU CC Feb 9, 8 am estSavant-January 26
179who benefits from class action suits? Well, class action lawyers. When you hear Savant-January 23
178Veru Announces Appointment of Dr. David D. Ho as Chairman of its Infectious DiseSavant-January 10
177Veru Reports Fiscal 2022 Fourth Quarter and Full Year Financial Results U.S. Savant-12/5/2022
176Veru to Report Fiscal 2022 Fourth Quarter and Full Year Financial Results oSavant-11/29/2022
175So, dropped into 5s in premar...has rallied to 7s;;;for now.....now, to wait to Savant-11/10/2022
174VERU...adcomm voted 8 to 5 to against recommending EUA...tomorrow might be nastySavant-11/9/2022
173so, 55 million shares traded, a pop up 52% high, caused by this news today So, Savant-11/7/2022
172VERU up 41% from Friday...meeting with adcomm on 9th////filled the gap from 14.0Savant-11/7/2022
171upcoming Covid 19 drug reviews....FDA, Nov 9...Adcom review.. later... UK, AustSavant-11/3/2022
170VERU further on pipeline Oncology program: The Company’s late-stage breast canSavant-11/3/2022
169MIAMI, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceSavant-10/25/2022
168seekingalpha.com an opinion piece ...disputes some of the short sellers argumenSavant-10/18/2022
167AG...likely fill the gap from 14.07Savant-10/3/2022
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2023 Knight Sac Media.  Data provided by IEX, Alpha Vantage, Coinbase, Binance, Fintel and CityFALCON News